جست‌وجوی استاد و پژوهشگر

Britta Leiseمشاهده پروفایل

دانشیار

• Inflammatory Conditions in Horses
• Laminitis
• Regenerative Medicine
• +۳ مورد دیگر

Dr. Britta Leise serves as Associate Professor of Equine Surgery and Associate Dean for Staff and Faculty Advancement at the LSU School of Veterinary Medicine, Louisiana State University, where she has been faculty since October 2015. A Diplomate of the American College of Veterinary Surgeons (Large Animal), she integrates clinical expertise with academic leadership in advancing veterinary education and research. Her academic credentials include: PhD, The Ohio State University (2010) DVM, Louisiana State University (2002) MS, Louisiana State University (1997) BS, Virginia Tech (1995) Dr. Leise's research program centers on equine inflammatory conditions , with specialized focus on laminitis pathogenesis , sepsis, osteoarthritis, and wound healing. She pioneers applications of regenerative medicine —particularly mesenchymal stem cell therapies—to modulate inflammatory responses in horses. Her clinical expertise spans equine surgery and lameness, with emphasis on hoof disorders and gastrointestinal conditions. Analysis of her 13 publications (2015-2023) reveals consistent output in high-impact veterinary journals, with increasing focus on molecular mechanisms of laminitis and translational applications of regenerative therapies. Recent work (2023) explores histological comparisons of lamellar tissue, stress responses in laminitis, and pharmacological cytotoxicity. Her professional recognition includes: Diplomate, American College of Veterinary Surgeons (Large Animal) Dr. Leise has secured over $40,000 in research funding since 2015 from sources including LSU internal programs, the Charles V. Cusimano Equine Health Studies Program, and the American College of Veterinary Surgeons Foundation. She mentors veterinary students and residents in surgical skills and clinically relevant topics across musculoskeletal, gastrointestinal, and respiratory systems. Her research group operates within the Department of Veterinary Clinical Sciences, conducting studies on inflammatory pathways and therapeutic interventions without a formally named laboratory entity.

• Allergy
• Diagnostic Immunology
• Primary Immunodeficiency
• +۴ مورد دیگر

Dr. Michael Tarzi is an Associate Professor (Honorary Consultant) in Clinical Immunology at Brighton and Sussex Medical School (BSMS), part of the University of Sussex. He serves as Immunology theme lead for module 204 and Phase 2 Lead, demonstrating significant academic leadership within the medical school. His expertise spans several key areas in immunology: Allergy and allergic disease mechanisms Diagnostic immunology Primary immunodeficiency disorders C1 inhibitor deficiency and hereditary angioedema Pollen-food syndrome Dr. Tarzi's research has significantly contributed to national guidelines and consensus documents, particularly in the management of C1 inhibitor deficiency. His work bridges clinical practice and academic research, with numerous publications in high-impact journals including Clinical and Experimental Immunology, Allergy, and the New England Journal of Medicine. His notable scientific contributions include: Co-authoring the 2014 United Kingdom consensus document on C1 inhibitor deficiency Contributing to a landmark 2017 NEJM study on prevention of hereditary angioedema attacks Leading research on T cell responses in allergic disease Conducting national audits on hereditary angioedema service provision As an educator, Dr. Tarzi has shaped medical curriculum development at BSMS since 2008, with particular focus on immunology education for medical students. His dual role as academic and Honorary Consultant ensures his teaching remains clinically relevant and up-to-date with current practice. Dr. Tarzi has secured research funding, including a project on "Viscero-sensory processes and neural responses to inflammation: mechanisms of pain and fatigue in fibromyalgia" funded by ARTHRITIS RESEARCH UK from 2016-2020, demonstrating his ability to obtain competitive research grants.

Joshua Havelinمشاهده پروفایل

استادیار

• Neuroscience
• Pain Research
• Biochemistry
• +۴ مورد دیگر

Joshua Havelin is an Assistant Professor of Chemistry at Thomas College, holding a Ph.D. in Biomedical Sciences (Neuroscience) from the University of Maine (2019) and a B.S. in Biochemistry and Medical Biology with honors from the University of New England (2011). His academic background includes: Ph.D. in Biomedical Sciences (Neuroscience focus), University of Maine, 2019 B.S. in Biochemistry and Medical Biology (with honors), University of New England, 2011 Dr. Havelin's research investigates chronic pain mechanisms in cancer-induced bone pain and osteoarthritis, focusing on sensory neuron subsets that drive drug-resistant phenotypes. Using transgenic and pharmacological tools, his work identifies distinct pathways for ongoing pain versus movement-evoked breakthrough pain, aiming to discover novel therapeutic targets for poorly managed chronic conditions. His 2013-2019 publications reveal consistent exploration of pain modulation mechanisms, particularly how kappa opioid receptors, cannabinoid 2 agonists, and specific nociceptor populations (e.g., IB4-binding neurons) influence cancer and osteoarthritis pain. Key trends include dissecting neuroimmune interactions in inflammatory pain and validating exercise interventions for joint pain. Scientific recognitions include: Nominated for Student Mentorship and Advising Award (Spring 2022) Society for Neuroscience Trainee Professional Development Award (Fall 2017) 1st place in University of New England Spring Undergraduate Research Symposium (Spring 2010) University of New England Summer Stipend recipient (Summer 2009) He actively mentors students as Chemistry Club Advisor (2023-2024) and Pre-Health Professions Advisory Committee member (2022), emphasizing experiential learning. Community engagement includes judging the Maine State Science Fair (2015-2022) and Maine Research Symposium (2022), while his interdisciplinary approach bridges biochemistry with home brewing and cooking hobbies. Dr. Havelin collaborates with researchers like Tamara King on pain mechanisms, leveraging rodent models to study neuronal contributions to cancer pain. His current role at Thomas College involves developing research infrastructure for undergraduate pain neuroscience projects, though specific lab details remain unstated in available materials.

• Complementary and Alternative Medicine
• Nutrition Science
• Clinical Pharmacology
• +۳ مورد دیگر

Kaj Winther serves as an Affiliate Professor in the Department of Nutrition, Exercise and Sports at the University of Copenhagen, specializing in evidence-based evaluation of complementary and alternative medicine interventions. His academic work bridges clinical pharmacology, nutritional science, and preventive healthcare through rigorous randomized controlled trials. Winther's research focuses on clinical validation of herbal and nutritional compounds for common health conditions. He investigates turmeric for osteoarthritis, rose hip for cold prevention and dermatological applications, pollen extracts for premenstrual symptoms, and Rauvolfia-Citrus formulations for diabetes management. His methodology emphasizes standardized plant material preparation, synergistic interactions, and real-world population studies, contributing significantly to the scientific credibility of traditional remedies. Analysis of his publication timeline (2011-2024) reveals consistent advancement in clinical trial design for natural products, with recent work expanding into systems vaccinology for HPV vaccine safety assessment. His research demonstrates methodological evolution from single-compound studies to complex multi-ingredient formulations, maintaining focus on musculoskeletal disorders, metabolic health, and women's reproductive conditions while incorporating modern biomarker analysis. He operates within the Clinical Preventive Nutrition research group at the University of Copenhagen, which investigates dietary strategies for disease prevention. This affiliation positions his work at the intersection of public health nutrition and clinical pharmacology, addressing translational gaps between traditional medicine practices and evidence-based healthcare standards.